Biogen Inc. (BIIB): Price and Financial Metrics

Biogen Inc. (BIIB): $194.38

3.86 (+2.03%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

Add BIIB to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#99 of 362

in industry

BIIB Price/Volume Stats

Current price $194.38 52-week high $319.76
Prev. close $190.52 52-week low $189.44
Day low $189.44 Volume 1,599,700
Day high $194.53 Avg. volume 1,162,021
50-day MA $216.16 Dividend yield N/A
200-day MA $245.31 Market Cap 28.26B

BIIB Stock Price Chart Interactive Chart >


Biogen Inc. (BIIB) Company Bio


Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide.(Source:Wikipedia)


BIIB Latest News Stream


Event/Time News Detail
Loading, please wait...

BIIB Latest Social Stream


Loading social stream, please wait...

View Full BIIB Social Stream

Latest BIIB News From Around the Web

Below are the latest news stories about BIOGEN INC that investors may wish to consider to help them evaluate BIIB as an investment opportunity.

12 Best Stocks to Buy for an 18 Year Old

In this article, we discuss the 12 best stocks to buy for an 18 year old. If you want to skip our detailed analysis of these stocks, go directly to 5 Best Stocks to Buy for an 18 Year Old. It is an exciting time to be involved in trading stocks. The Federal Reserve in […]

Yahoo | December 28, 2023

Healthcare Heroes: 3 Stocks Innovating in Medicine and Wellness

Discover these innovative healthcare stocks, backed by the U.S.'s $4.3 trillion health investment, offering stability and high returns.

Muslim Farooque on InvestorPlace | December 27, 2023

Top 3 Healthcare Stock Picks for the New Year

Buy these healthcare stocks for 2024 trading at bargain prices before their earnings inflect higher on improving fundamentals.

Charles Munyi on InvestorPlace | December 26, 2023

Ionis (IONS), AstraZeneca's Eplontersen Receives FDA Nod

FDA approves Ionis (IONS) and partner AstraZeneca's (AZN) Wainua for treating ATTRv-PN. Ionis stock rises on this important milestone.

Yahoo | December 22, 2023

Is Eli Lilly Stock A Buy Or A Sell As Shares Seesaw On Recent Obesity Drug Findings?

Is Eli Lilly stock a buy or a sell as shares seesaw in the wake of new Zepbound test results? LLY stock a buy or a sell right now?

Yahoo | December 20, 2023

Read More 'BIIB' Stories Here

BIIB Price Returns

1-mo -10.88%
3-mo -21.72%
6-mo -22.90%
1-year -33.88%
3-year -24.95%
5-year -15.56%
YTD -24.88%
2023 -6.55%
2022 15.42%
2021 -2.02%
2020 -17.48%
2019 -1.39%

Continue Researching BIIB

Want to see what other sources are saying about Biogen Inc's financials and stock price? Try the links below:

Biogen Inc (BIIB) Stock Price | Nasdaq
Biogen Inc (BIIB) Stock Quote, History and News - Yahoo Finance
Biogen Inc (BIIB) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!